DHC
DHC
Diversified Healthcare TrustIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $379.57M ▼ | $-40.37M ▼ | $-21.22M ▲ | -5.59% ▲ | $-0.09 ▲ | $136.27M ▲ |
| Q3-2025 | $388.71M ▲ | $78.11M ▲ | $-164.04M ▼ | -42.2% ▼ | $-0.68 ▼ | $-53.77M ▼ |
| Q2-2025 | $382.71M ▼ | $77.44M ▲ | $-91.64M ▼ | -23.94% ▼ | $-0.38 ▼ | $23.34M ▼ |
| Q1-2025 | $386.86M ▲ | $9M ▲ | $-8.99M ▲ | -2.32% ▲ | $-0.04 ▲ | $63.54M ▼ |
| Q4-2024 | $379.62M | $1.25M | $-87.45M | -23.04% | $-0.36 | $65.44M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $105.41M ▼ | $4.36B ▼ | $2.7B ▼ | $1.67B ▼ |
| Q3-2025 | $201.37M ▲ | $4.68B ▼ | $3B ▲ | $1.69B ▼ |
| Q2-2025 | $141.77M ▼ | $4.76B ▼ | $2.9B ▼ | $1.85B ▼ |
| Q1-2025 | $302.58M ▲ | $5B ▼ | $3.05B ▼ | $1.95B ▼ |
| Q4-2024 | $144.58M | $5.14B | $3.18B | $1.96B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-21.22M ▲ | $28.29M ▲ | $159.02M ▲ | $-275.13M ▼ | $-87.82M ▼ | $-16.38M ▲ |
| Q3-2025 | $-164.04M ▼ | $-49.28M ▼ | $6.12M ▲ | $104.21M ▲ | $61.04M ▲ | $-49.28M ▼ |
| Q2-2025 | $-91.64M ▼ | $53.02M ▲ | $-21.05M ▼ | $-190.04M ▼ | $-158.07M ▼ | $53.02M ▲ |
| Q1-2025 | $-8.99M ▲ | $-3.24M ▼ | $291.09M ▲ | $-131.05M ▼ | $156.8M ▲ | $-3.24M ▼ |
| Q4-2024 | $-87.45M | $18.2M | $-66.14M | $-63.6M | $-111.55M | $18.2M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Rental Income | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ |
Resident Fees And Services | $330.00M ▲ | $330.00M ▲ | $330.00M ▲ | $320.00M ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Diversified Healthcare Trust's financial evolution and strategic trajectory over the past five years.
DHC’s key strengths include a sizable and diversified healthcare real estate portfolio, a very conservative balance sheet with little to no debt, and a strong cash position built through extensive asset sales. Its exposure to senior housing, medical office, and life science facilities aligns it with powerful long‑term demand drivers, especially an aging population and growing healthcare and research needs. Management has shown a willingness to take hard decisions—selling large numbers of properties and focusing on portfolio quality—to stabilize the business and simplify the capital structure. Sustainability and tenant‑focused initiatives further support the appeal of its properties.
The most significant risks revolve around weak current profitability and negative operating cash flow. The business is not yet generating enough cash from its properties to fully support itself, and recent stability has relied heavily on one‑off asset sale proceeds. If operational performance does not improve, the company may eventually need to sell additional properties, accept smaller scale, or consider other strategic options. Execution risk in senior housing, operator performance, local market conditions, and broader healthcare and interest rate environments all add uncertainty. The unusual financial profile—no debt, no current liabilities, no retained earnings, and atypical margin metrics—also suggests that investors should treat reported figures with caution and seek more detail from full filings.
DHC appears to be in the later stages of a major restructuring and portfolio repositioning. The balance sheet now looks relatively strong and low‑risk, giving management room to focus on fixing operations rather than worrying about near‑term solvency. Guidance for improved cash‑based performance metrics indicates management’s confidence that a leaner, higher‑quality portfolio can generate better earnings over the next couple of years. However, turning that guidance into reality will require sustained improvement in occupancy, rents, and cost control, particularly in senior housing, and a shift from relying on asset sales to generating cash from operations. The forward picture is that of a higher‑quality but smaller REIT that could gradually move from stabilization to growth, provided execution risks are managed successfully.
About Diversified Healthcare Trust
https://www.dhcreit.comDHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $379.57M ▼ | $-40.37M ▼ | $-21.22M ▲ | -5.59% ▲ | $-0.09 ▲ | $136.27M ▲ |
| Q3-2025 | $388.71M ▲ | $78.11M ▲ | $-164.04M ▼ | -42.2% ▼ | $-0.68 ▼ | $-53.77M ▼ |
| Q2-2025 | $382.71M ▼ | $77.44M ▲ | $-91.64M ▼ | -23.94% ▼ | $-0.38 ▼ | $23.34M ▼ |
| Q1-2025 | $386.86M ▲ | $9M ▲ | $-8.99M ▲ | -2.32% ▲ | $-0.04 ▲ | $63.54M ▼ |
| Q4-2024 | $379.62M | $1.25M | $-87.45M | -23.04% | $-0.36 | $65.44M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $105.41M ▼ | $4.36B ▼ | $2.7B ▼ | $1.67B ▼ |
| Q3-2025 | $201.37M ▲ | $4.68B ▼ | $3B ▲ | $1.69B ▼ |
| Q2-2025 | $141.77M ▼ | $4.76B ▼ | $2.9B ▼ | $1.85B ▼ |
| Q1-2025 | $302.58M ▲ | $5B ▼ | $3.05B ▼ | $1.95B ▼ |
| Q4-2024 | $144.58M | $5.14B | $3.18B | $1.96B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-21.22M ▲ | $28.29M ▲ | $159.02M ▲ | $-275.13M ▼ | $-87.82M ▼ | $-16.38M ▲ |
| Q3-2025 | $-164.04M ▼ | $-49.28M ▼ | $6.12M ▲ | $104.21M ▲ | $61.04M ▲ | $-49.28M ▼ |
| Q2-2025 | $-91.64M ▼ | $53.02M ▲ | $-21.05M ▼ | $-190.04M ▼ | $-158.07M ▼ | $53.02M ▲ |
| Q1-2025 | $-8.99M ▲ | $-3.24M ▼ | $291.09M ▲ | $-131.05M ▼ | $156.8M ▲ | $-3.24M ▼ |
| Q4-2024 | $-87.45M | $18.2M | $-66.14M | $-63.6M | $-111.55M | $18.2M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Rental Income | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ |
Resident Fees And Services | $330.00M ▲ | $330.00M ▲ | $330.00M ▲ | $320.00M ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Diversified Healthcare Trust's financial evolution and strategic trajectory over the past five years.
DHC’s key strengths include a sizable and diversified healthcare real estate portfolio, a very conservative balance sheet with little to no debt, and a strong cash position built through extensive asset sales. Its exposure to senior housing, medical office, and life science facilities aligns it with powerful long‑term demand drivers, especially an aging population and growing healthcare and research needs. Management has shown a willingness to take hard decisions—selling large numbers of properties and focusing on portfolio quality—to stabilize the business and simplify the capital structure. Sustainability and tenant‑focused initiatives further support the appeal of its properties.
The most significant risks revolve around weak current profitability and negative operating cash flow. The business is not yet generating enough cash from its properties to fully support itself, and recent stability has relied heavily on one‑off asset sale proceeds. If operational performance does not improve, the company may eventually need to sell additional properties, accept smaller scale, or consider other strategic options. Execution risk in senior housing, operator performance, local market conditions, and broader healthcare and interest rate environments all add uncertainty. The unusual financial profile—no debt, no current liabilities, no retained earnings, and atypical margin metrics—also suggests that investors should treat reported figures with caution and seek more detail from full filings.
DHC appears to be in the later stages of a major restructuring and portfolio repositioning. The balance sheet now looks relatively strong and low‑risk, giving management room to focus on fixing operations rather than worrying about near‑term solvency. Guidance for improved cash‑based performance metrics indicates management’s confidence that a leaner, higher‑quality portfolio can generate better earnings over the next couple of years. However, turning that guidance into reality will require sustained improvement in occupancy, rents, and cost control, particularly in senior housing, and a shift from relying on asset sales to generating cash from operations. The forward picture is that of a higher‑quality but smaller REIT that could gradually move from stabilization to growth, provided execution risks are managed successfully.

CEO
Christopher J. Bilotto
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 115
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
FLAT FOOTED LLC
Shares:23.49M
Value:$158.77M
BLACKROCK, INC.
Shares:23.03M
Value:$155.68M
VANGUARD GROUP INC
Shares:19.77M
Value:$133.63M
Summary
Showing Top 3 of 253

